Longitude Capital Partners II, LLC Insider Trading $AIMT Aimmune Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Longitude Capital Partners II, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners II, LLC. Longitude Capital Partners II, LLC is 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and in Tricida, Inc. ($TCDA) and 10% Owner in Aimmune Therapeutics, Inc. ($AIMT) and 10% Owner in Aptinyx Inc. ($APTX).
Longitude Capital Partners II, LLC in Aimmune Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners II, LLC: 10% Owner
Holdings: 6,013,134 shares
Current Value: $112,205,080
Latest Transaction: Dec 01 2016
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Longitude Capital Partners II, LLC in Aimmune Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, APTX, KALA, TCDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 01 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | J | 0.00 | 7,276 | 0 | 7,276 | 0 to 7.3 K |
| Dec 01 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 6,013,134 | 7.5 M to 6 M (-19.97 %) |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 14.15 | 45,440 | 642,817 | 7,513,134 | 7.5 M to 7.5 M (+0.61 %) |
| Mar 31 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 13.50 | 33,064 | 446,318 | 7,467,694 | 7.4 M to 7.5 M (+0.44 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,248,600 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,873,530 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 7,434,630 | 7.1 M to 7.4 M (+4.39 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,248,600 | 0 | 7,122,130 | 3.9 M to 7.1 M (+83.87 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,873,530 | 0 | 3,873,530 | 0 to 3.9 M |
Page: 1